Zacks Investment Research
29 Jun 2026, 22:51 UTC · 1h ago
Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
29 Jun 2026, 22:51 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Adma Biologics (ADMA) currently holds a Zacks Rank of #5 (Strong Sell). — A 'Strong Sell' rating from a proprietary model focused on estimate revisions typically signals negative short-term price momentum.
-0.60The Zacks Consensus EPS estimate for Adma Biologics has decreased by 2.38% over the last 30 days. — Downward revisions in earnings expectations generally lead to lowered valuation targets by analysts.
-0.40Adma Biologics is expected to post quarterly earnings of $0.16 per share and revenue of $125.77 million, representing year-over-year growth of 6.67% and 3.11% respectively. — Modest growth in both top and bottom lines provides a baseline of fundamental stability.
+0.20Continue reading
6 related stories
Top 1 mover · tap to explore
Adma Biologics has a Forward P/E ratio of 10.67, which is a significant discount compared to the industry average of 21.95. — A lower-than-average P/E may attract value investors, though it often reflects the market's skepticism captured in the Strong Sell rank.
Which stocks this story touches
The company is assigned a Zacks Rank of #5 (Strong Sell) and recently lagged the S&P 500 with a 4.34% price drop.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
1h ago
